Avison Young has reported that there has been a decline in venture capital funding for life sciences in the Bay Area, resulting in a rise in vacancies in the sector. In the fourth quarter of 2023, VC funding barely surpassed $500 million, compared to the boom in funding seen from 2020 to mid-2022, when quarterly funding regularly exceeded $2 billion. Avison Young suggests that the decrease in funding is due to the waning allure of biopharmaceutical investments and the increasing focus on the AI industry. As a result, more life science companies are choosing to sublease their spaces, leading to a steady increase in vacancies since 2022. With over seven million square feet of life science space currently under construction, the market is likely to face a vacancy issue in the coming years.
Surging Job Opportunities in Bay Area’s Thriving Life Science
Latest from Blog
Venture Capital News: Avail, M^0, Sandbox Secure Millions in Funding
VC Roundup Summary TLDR: Key Points: 21 startups raised $399.7 million in VC funding in the blockchain space from June 2 to June 8. Avail secured $43 million, M^0 raised $35 million,
American Tech Industry Pushes Chinese VC to Liquidate Investments
TLDR: US tech sector pressures Chinese venture capital to divest Chinese venture capital firms facing pressure to divest from US tech sector due to national security concerns In a move driven by
Middle East’s Position in Global AI Funding Race
TLDR: Global venture capital funds are investing in AI in the Middle East, showing solid interest in the region’s technology industry and potential. The UAE and Saudi Arabia are leading the AI
Unveiling the Power of Venture Capital in Driving Innovation
TLDR: FICCI Ladies Organisation (FLO) Hyderabad organized a session on the role of venture capitalists in innovation. Priya Gazdar highlighted the history of venture capitalism, emphasizing the importance of behavior in founders
Nascent Ventures amasses 445 billion PEPE coins in savvy maneuver
TLDR: Nascent Ventures acquires over 445 billion PEPE coins worth $5.48 million in a strategic move. The strategic investment by Nascent highlights their optimistic stance on PEPE’s prospects and solidifies PEPE’s status